Grace Therapeutics (GRCE) Research & Development (2019 - 2026)
Grace Therapeutics (GRCE) reported Research & Development of $697,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 27.0% from $955,000 a year earlier but up 66.0% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Research & Development (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Grace Therapeutics' Research & Development came in at $2.15 million, down 72.3% year-over-year; for FY2026 (ended Mar 31, 2026), it was $2.41 million, down 74.7% from FY2025.
- Research & Development has a five-year compound annual growth rate of -10.4% (FY2021 to FY2026).
- By fiscal year, Research & Development came in at $9.51 million in FY2025 (+103.1%), $4.68 million in FY2024 (-53.0%), $9.97 million in FY2023 (+79.4%) and $5.56 million in FY2022 (+33.2%).
- Five-year quarterly Research & Development spans a low of $420,000 in fiscal Q4 2026 and a high of $3.29 million in fiscal Q2 2023.
- Year over year, Research & Development has now declined in each of the last six quarters, with growth averaging 33.8% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was fiscal Q2 2025 (growth of 547.0%); the low point was fiscal Q2 2024 (a decline of 86.0%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $420,000 (Q4 2026), $462,000 (Q3 2026) and $568,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Grace Therapeutics | 34.50 Mn | 34.50 Mn | - | 697,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 697,000.00 |
| Mar 31, 2026 | 420,000.00 |
| Dec 31, 2025 | 462,000.00 |
| Sep 30, 2025 | 568,000.00 |
| Jun 30, 2025 | 955,000.00 |
| Mar 31, 2025 | 1.63 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.98 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 460,000.00 |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.64 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 3.29 Mn |
| Jun 30, 2022 | 2.59 Mn |
| Mar 31, 2022 | 2.33 Mn |
| Dec 31, 2021 | 2.18 Mn |
| Sep 30, 2021 | 585,000.00 |
API Access
Grace Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();